Periodontal Disease Market to Register Incremental Growth During the Forecast Period 2030 | Key Companies – Dexcel Pharma, CollaGenex, Kaken Pharma, Yuhan Corporation and Others

October 08 01:15 2021
Periodontal Disease Market to Register Incremental Growth During the Forecast Period 2030 |  Key Companies - Dexcel Pharma, CollaGenex, Kaken Pharma, Yuhan Corporation and Others
Delveinsight Business Research LLP
DelveInsight’s “Periodontal Disease Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Periodontal Disease Market Size and Share in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Periodontal Disease market report covers emerging drugs, current treatment practices, market share of the individual therapies, current and forecasted market size from 2017 to 2030. It evaluates the current treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Periodontal Disease Market

Periodontal Disease: An Overview

According to The American Academy of Periodontology, “Periodontal Diseases are bacterial gum infections that destroy the gums and supporting bone that holds our teeth in our mouth. Periodontal diseases can affect one tooth or many teeth. The main cause of periodontal diseases is a bacterial plaque which is a sticky, colorless film that constantly forms on the teeth. If the plaque is not removed, it can turn into a hard substance called calculus or tartar in less than two days.

Periodontal Disease Market Key Facts

  • According to the CDC, in the United States Periodontal Disease is more common in men than women (56.4% vs. 38.4%).

  • As per the CDC, the prevalence of periodontitis in the U.S., 47.2% of adults aged 30 years and older have some form of periodontal disease which increases with age. 70.1% of adults 65 years and older have periodontal disease.

  • According to Tonetti et al. 2017, severe periodontitis is the 6th most prevalent disease worldwide, with an overall prevalence of 11.2% and around 743 million.

Get FREE sample copy at:

Key Benefits of Periodontal Disease Market Report

  • The report provides an in-depth analysis of Periodontal Disease Market Size and Share till 2030 in the seven major markets.

  • The report will help in developing business strategies by understanding the Periodontal Disease Market Trends, key players, and ongoing developments that shape and drive the market growth in the upcoming years.

  • It covers Periodontal Disease current treatment practices, emerging drugs, market share of the individual therapies in the 7MM.

  • The report provides a detailed assessment of the Periodontal Disease market in terms of market drivers & barriers, unmet needs, market opportunities, patient population, detailed comparative analysis of pipeline products including clinical and non-clinical stage products, and other factors. 

Periodontal Disease Market 

The market size of Periodontal Disease is expected to increase during the forecast period owing to the extensive research and development activities of pharmaceutical companies along with the emerging therapies in the pipeline, and the rising prevalent population in the seven major markets.

The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Periodontal Disease market size and share by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology. 

The report gives a thorough detail of the Periodontal Disease market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Periodontal Disease Epidemiology

The epidemiology section covers insights about the historical and current Periodontal Disease patient pool and forecasted trends for every seven major countries from 2017 to 2030. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

Periodontal Disease Epidemiology Segmentation

  • Prevalent cases of Periodontal Disease

  • Gender-specific Prevalent cases of Periodontal Disease

  • Diagnosed Prevalent Cases of Periodontal Disease 

  • Treatable Prevalent Cases of Periodontal Disease

Periodontal Disease Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Periodontal Disease market or expected to get launched in the market during the study period. The analysis covers Periodontal Disease market uptake by drugs; patient uptake by therapies; and sales of each drug. 

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Periodontal Disease Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisitions, and mergers, licensing patent details, and other information for emerging therapies.

Key companies in the Periodontal Disease market include:

  • Dexcel Pharma Technologies

  • CollaGenex Pharmaceuticals

  • Kaken Pharmaceuticals

  • Yuhan Corporation 

And many other 

Periodontal Disease Therapies covered in the report includes:

  • PerioChip

  • YH23537

And many others.

Request for Sample @ Periodontal Disease Therapeutics Market Assessment

Table of Content

1. Key Insights

2. Executive Summary 

3. Periodontal Disease Competitive Intelligence Analysis

4. Periodontal Disease Market Overview at a Glance

5. Periodontal Disease Disease Background and Overview

6. Periodontal Disease Patient Journey

7. Periodontal Disease Epidemiology and Patient Population

8. Periodontal Disease Treatment Algorithm, Current Treatment, and Medical Practices

9. Periodontal Disease Unmet Needs

10. Key Endpoints of Periodontal Disease Treatment

11. Periodontal Disease Marketed Products

12. Periodontal Disease Emerging Therapies

13. Periodontal Disease Seven Major Market Analysis

14. Attribute Analysis

15. Periodontal Disease Market Outlook (7 major markets)

16. Periodontal Disease Access and Reimbursement Overview

17. KOL Views on the Periodontal Disease Market.

18. Periodontal Disease Market Drivers

19. Periodontal Disease Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The table of contents is not exhaustive; the final content may vary. 

Get FREE sample copy at:

Healthcare Blogs

Data Breaches in Healthcare Organizations

The data breach is one of the major concerns in today’s information age. Over the past few years, several cases have emerged where companies from different sectors have acknowledged the breach in their system. Like other sectors, for the companies operating in the healthcare domain, it is like a nightmare to lose customers’ sensitive medical and health data. The Healthcare Data Breaches has a direct implication on the customer and for the companies, it costs their reputation and market share. Read More: Data Breaches in Healthcare Sector

Myasthenia Gravis Market Outlook

To fulfill the unmet need in Myasthenia Gravis Market, several pharmaceutical companies across the globe, such as Valeant Pharmaceuticals, Astellas Pharma, Viela Bio, UCB, argenx, Alexion Pharmaceuticals, Grifols, The Janssen Pharmaceutical Companies of Johnson & Johnson, Roche, and others, are testing their drug candidates with novel MoA that can be used as first-line of therapy or second-line of treatment. Read More: Myasthenia Gravis Market

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States